Boceprevir Plus Peginterferon Alfa-2a/Ribavirin in Treatment-Naïve Hepatitis C Virus Genotype 1 Patients: International Phase IIIb/IV TriCo Trial

Boceprevir Plus Peginterferon Alfa-2a/Ribavirin in Treatment-Naïve Hepatitis C Virus Genotype 1 Patients: International Phase IIIb/IV TriCo Trial

Bibliographic Details
Main Authors: Ferenci, Peter, Caruntu, Florin A., Lengyel, Gabriella, Messinger, Diethelm, Bakalos, Georgios, Flisiak, Robert
Format: Online
Language:English
Published: Springer Healthcare 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4929089/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4929089/

Similar Items